KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dynavax Technologies (DVAX) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for Dynavax Technologies (DVAX) over the last 17 years, with Q3 2025 value amounting to $946.5 million.

  • Dynavax Technologies' Liabilities and Shareholders Equity fell 1087.43% to $946.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.8 billion, marking a year-over-year decrease of 651.98%. This contributed to the annual value of $986.3 million for FY2024, which is 108.72% down from last year.
  • According to the latest figures from Q3 2025, Dynavax Technologies' Liabilities and Shareholders Equity is $946.5 million, which was down 1087.43% from $918.4 million recorded in Q2 2025.
  • Dynavax Technologies' Liabilities and Shareholders Equity's 5-year high stood at $1.1 billion during Q3 2024, with a 5-year trough of $490.1 million in Q1 2021.
  • Moreover, its 5-year median value for Liabilities and Shareholders Equity was $985.8 million (2022), whereas its average is $939.6 million.
  • Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first surged by 19417.73% in 2021, then plummeted by 1087.43% in 2025.
  • Over the past 5 years, Dynavax Technologies' Liabilities and Shareholders Equity (Quarter) stood at $1.0 billion in 2021, then fell by 5.14% to $985.8 million in 2022, then increased by 1.14% to $997.1 million in 2023, then decreased by 1.09% to $986.3 million in 2024, then dropped by 4.03% to $946.5 million in 2025.
  • Its Liabilities and Shareholders Equity stands at $946.5 million for Q3 2025, versus $918.4 million for Q2 2025 and $945.9 million for Q1 2025.